biotech

Converse of object

• lead: It is high tech with sector leading biotech & ICT clusters.
• say: For this reason I am in favor of supporting the research, however we cannot say that biotech can solve world hunger.
• include: The customer base will include academic, biotech and pharma companies and include both system sales and associated kits.

Adjective modifier

• agricultural: The percentage of new biotech companies across the EU involved in agricultural biotech has dropped dramatically over recent years.
• new: The new biotech is already subject to illogical, unscientific, excessive, regulation, but the activists demand more.
• academic: You will be dealing with academic, biotech and pharma accounts promoting a range of research products.
• leading: Genetix has established a broad and strong customer base among many of the world's leading biotech and pharmaceutical companies & research institutions.

Modifies a noun

• crop: Q: How do you know the products of biotech crops are safe for animals to eat?
• soybean: The USDA predicts biotech soybean acreage will increase to 54 million, 3.3 million more than last year.
• acreage: The USDA predicts biotech soybean acreage will increase to 54 million, 3.3 million more than last year.
• corn: Biotech corn, which is already widely used now in South Africa, produces its own protection against the corn borer.
• giant: There is particular concern about GM maize produced by the biotech giant Novartis.
• cotton: This is an increase of 28 percent from the 2000 biotech cotton acreage, which was approximately 5.3 million hectares.

Noun used with modifier

• plant: India's budget is about 20 % that of China, China accounts for more than half of the developing world's expenditures on plant biotech.
• ag: Additionally, there a total of 63 countries doing research on ag biotech.
• crop: Issued last week, the report favors crop biotech for poor farmers in developing nations.
• food: Even the corporations are coming around to the view that " Food biotech is dead " [ 28 ] .
• stage: The European Investment Fund has increased investment via private sector venture capital funds for early stage biotech companies.
• edge: Clients range from small businesses in all markets to government departments, reputed international training companies, cutting edge biotech and motor manufacturers.